- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 02-02-2026: Press Release
02-02-2026 | 11:02 am
02-02-2026 | 11:02 am
Lupin launched Dasatinib Tablets in the U.S., a key business development. This product targets a market with estimated annual sales of USD 930 million. Developed with Pharmascience, this launch strengthens Lupin's U.S. portfolio.
No comments yet. Be the first to comment!